CMTM5 and central nervous system cancer: This is the first study to demonstrate that CMTM5, which suppressed WWP2 expression through interacting with WWP2 protein, inhibited cell growth and promoted ferroptosis by attenuating WWP2‐mediated LATS2 ubiquitination and degradation, thereby alleviating glioma progression.